Skip to content
Disclosery

Wildcat Capital Management, LLC

Follow

13F filer, CIK 1582384, NEW YORK, NY

Wildcat Capital Management, LLC reported $228,529,463 across 3 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-07-22.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001999371-26-015582

Period
2026-06-30
Reported value
$229M
Holdings
3
Top 10 weight
100%
New
1
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CHYMnew+23,874$489K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001999371-26-015582, largest first. % of portfolio is the value over $228,529,463, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ULCCFRONTIER GROUP HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 28,061,351 shares; 2024Q4: 28,061,351 shares; 2025Q1: 28,061,351 shares; 2025Q2: 28,061,351 shares; 2025Q3: 28,061,351 shares; 2025Q4: 28,061,351 shares; 2026Q1: 28,061,351 shares; 2026Q2: 28,061,351 shares 28,061,351$222M97.13%0Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,920,787 shares; 2024Q4: 2,920,787 shares; 2025Q1: 2,920,787 shares; 2025Q2: 2,920,787 shares; 2025Q3: 2,920,787 shares; 2025Q4: 2,920,787 shares; 2026Q1: 2,920,787 shares; 2026Q2: 2,920,787 shares 2,920,787$6.08M2.66%0Timeline
CHYMCHIME FINL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 23,874 shares 23,874$489K0.21%newTimeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001999371-26-015582 base2026-07-22acceptance time not in the bulk data set